60 Degrees Pharmaceuticals (SXTP) Operating Margin (QoQ) (2022 - 2026)
60 Degrees Pharmaceuticals (SXTP) Operating Margin (QoQ) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.93 Bn | 131.08 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.11 Bn | 78.11 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.43 Bn | 60.25 Bn | 1.37 Bn |
| 4 | Moderna | 56.09 Bn | 50.96 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.13 Bn | 37.03 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.30 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.68 Bn | 9.29 Bn | 668.28 Mn |
| 8 | Insmed | 27.49 Bn | 26.32 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.36 Bn | 26.52 Bn | - |
| 10 | 60 Degrees Pharmaceuticals | 3.03 Mn | 2.00 Mn | 56,798.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -66,047.00 |
| Dec 31, 2025 | -10,056.00 |
| Sep 30, 2025 | 105,858.00 |
| Jun 30, 2025 | -42,161.00 |
| Mar 31, 2025 | -31,368.00 |
| Dec 31, 2024 | 71,129.00 |
| Sep 30, 2024 | 178,575.00 |
| Jun 30, 2024 | -208,138.00 |
| Mar 31, 2024 | -57,356.00 |
| Dec 31, 2023 | 227,608.00 |
| Sep 30, 2023 | -277,575.00 |
| Jun 30, 2023 | 533,899.00 |
| Sep 30, 2022 | 822.00 |